SAB Biotherapeutics SABS
NASDAQ SABS
$3.22 +0.01 (+0.16%)
At close: Sep 29, 2026 · 4:00 PM EDT

SAB Biotherapeutics (SABS) Total Liabilities (2020 - 2026)

Updated

SAB Biotherapeutics (SABS) reported Total Liabilities of $23.43 million for Q2 2026, up 29.3% from $18.11 million a year earlier and up 10.4% from the prior quarter.

Analysis

SAB Biotherapeutics (SABS) Total Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, SAB Biotherapeutics posted Total Liabilities of $21.32 million, up 17.0% from FY2024.

  • Total Liabilities has a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
  • By year, Total Liabilities came in at $18.23 million in FY2024 (-31.6%), $26.64 million in FY2023 (+34.2%), $19.85 million in FY2022 (-53.4%) and $42.59 million in FY2021 (+143.0%).
  • The Q2 2026 figure ranks as the highest quarterly Total Liabilities since Q4 2023.
  • Year over year, Total Liabilities has now increased in each of the last five quarters, with growth averaging 10.6% over the last eight quarters.
  • The high point for year-over-year Total Liabilities in five years was Q4 2021 (growth of 143.0%); the low point was Q3 2022 (a decline of 73.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $21.22 million (Q1 2026), $21.32 million (Q4 2025) and $18.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 SAB Biotherapeutics 268.01 Mn 268.01 Mn - 23.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.43 Mn
Mar 31, 2026 21.22 Mn
Dec 31, 2025 21.32 Mn
Sep 30, 2025 18.37 Mn
Jun 30, 2025 18.11 Mn
Mar 31, 2025 16.71 Mn
Dec 31, 2024 18.23 Mn
Sep 30, 2024 16.89 Mn
Jun 30, 2024 15.77 Mn
Mar 31, 2024 18.55 Mn
Dec 31, 2023 26.64 Mn
Sep 30, 2023 13.08 Mn
Jun 30, 2023 15.73 Mn
Mar 31, 2023 18.27 Mn
Dec 31, 2022 19.85 Mn
Sep 30, 2022 21.88 Mn
Jun 30, 2022 22.29 Mn
Mar 31, 2022 27.23 Mn
Dec 31, 2021 42.59 Mn
Sep 30, 2021 81.85 Mn
API Access

SAB Biotherapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=SABS&period=max&api_key=YOUR_API_KEY